OHE submission to the UK Parliamentary Inquiry on an Ageing Society urges UK policy to focus on healthy ageing, adult ...

Despite substantial medical advancements that have transformed HIV into a manageable chronic condition for individuals, the ...

Kenya has health reforms support Universal Health Coverage and HTA institutionalisation, despite challenges in funding, data, ...

Professor Graham Cookson responds to President Donald Trump's Executive Order on drug prices published earlier this week.

The glucagon-like peptide-1 (GLP-1) receptor agonist market is experiencing rapid growth, with more than 150 drug candidates currently in development as reported by Research & Markets, 2025. These ...

This calculator is built and hosted by OHE, and owned, funded, and commissioned by Pfizer. Before proceeding, please read the following important information regarding its use. This calculator ...

Rare disease medicine markets often rely on single suppliers, increasing the risk of shortages and limiting treatment options. Our report explores how supplier diversity can enhance healthcare ...

Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs and health-focused policies could help boost productivity, reduce costs, and ...